The Osteosarcoma Biobank in Peking University People's Hospital
Launched by PEKING UNIVERSITY PEOPLE'S HOSPITAL · Dec 2, 2017
Trial Information
Current as of June 18, 2025
Unknown status
Keywords
ClinConnect Summary
Samples of blood and other stored material such as slides,frozen tissues and so on .
Questionnaire information, including health history, growth and development, physical activity and family medical history information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma
- Exclusion Criteria:
- • non-asian pulmonary metastasis
About Peking University People's Hospital
Peking University People's Hospital is a leading clinical research institution in China, renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. Affiliated with Peking University, the hospital integrates cutting-edge research, comprehensive healthcare services, and a multidisciplinary team of experts to facilitate the development of new therapies and medical interventions. With a strong focus on patient safety and ethical standards, Peking University People's Hospital is dedicated to conducting rigorous clinical trials that contribute to the global medical community and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tingting Ren, phD
Principal Investigator
Peking University People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials